1. Home
  2. IVVD vs HPH Comparison

IVVD vs HPH Comparison

Compare IVVD & HPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • HPH
  • Stock Information
  • Founded
  • IVVD 2020
  • HPH 2010
  • Country
  • IVVD United States
  • HPH China
  • Employees
  • IVVD N/A
  • HPH N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • HPH
  • Sector
  • IVVD Health Care
  • HPH
  • Exchange
  • IVVD Nasdaq
  • HPH NYSE
  • Market Cap
  • IVVD 116.8M
  • HPH 137.1M
  • IPO Year
  • IVVD 2021
  • HPH 2019
  • Fundamental
  • Price
  • IVVD $0.70
  • HPH $0.32
  • Analyst Decision
  • IVVD Strong Buy
  • HPH
  • Analyst Count
  • IVVD 5
  • HPH 0
  • Target Price
  • IVVD $7.11
  • HPH N/A
  • AVG Volume (30 Days)
  • IVVD 581.2K
  • HPH 607.4K
  • Earning Date
  • IVVD 11-14-2024
  • HPH 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • HPH N/A
  • EPS Growth
  • IVVD N/A
  • HPH N/A
  • EPS
  • IVVD N/A
  • HPH N/A
  • Revenue
  • IVVD $11,564,000.00
  • HPH $286,996,105.00
  • Revenue This Year
  • IVVD N/A
  • HPH N/A
  • Revenue Next Year
  • IVVD $72.22
  • HPH N/A
  • P/E Ratio
  • IVVD N/A
  • HPH N/A
  • Revenue Growth
  • IVVD N/A
  • HPH 1722.42
  • 52 Week Low
  • IVVD $0.71
  • HPH $0.26
  • 52 Week High
  • IVVD $5.20
  • HPH $10.06
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 33.40
  • HPH 30.03
  • Support Level
  • IVVD $0.72
  • HPH $0.26
  • Resistance Level
  • IVVD $0.81
  • HPH $0.37
  • Average True Range (ATR)
  • IVVD 0.07
  • HPH 0.04
  • MACD
  • IVVD -0.02
  • HPH 0.02
  • Stochastic Oscillator
  • IVVD 1.12
  • HPH 34.17

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. It focuses on providing personalized wealth management services for emerging middle-class and affluent families, comprehensive support services for financial planners, and diversified financial services for institutional clients.

Share on Social Networks: